Faculty Bibliography

The melanoma removed in 2000 was Stage IIa on a standard classification that makes Stage IV the most serious. For Stage IIa melanoma, the survival rate 10 years after diagnosis is about 65 percent. But the outlook is much better for patients like [John McCain], who have already survived more than seven years. Even if the melanoma returns, McCain would not be the first sitting president to have had cancer. From what information he has disclosed, he is at increased risk for melanoma and other skin cancers because of his medical history, fair skin and prolonged sun exposure at a young age - long before the wide use of sunscreen. The most serious melanoma was spotted on his temple in 2000 by the attending physician at the U.S. Capitol after it had escaped the eye of McCain's personal physician at Mayo Clinic Scottsdale, in Arizona

The melanoma removed in 2000 was Stage IIa on a standard classification that makes Stage IV the most serious. For Stage IIa melanoma, the survival rate 10 years after diagnosis is about 65 percent. But the outlook is much better for patients like [John McCain], who have already survived more than seven years. Even if the melanoma returns, McCain would not be the first sitting president to have had cancer. From what information he has disclosed, he is at increased risk for melanoma and other skin cancers because of his medical history, fair skin and prolonged sun exposure at a young age - long before the wide use of sunscreen. The most serious melanoma was spotted on his temple in 2000 by the attending physician at the U.S. Capitol after it had escaped the eye of McCain's personal physician at Mayo Clinic Scottsdale, in Arizona. The Capitol physician also spotted the melanoma on his left arm

With modifications, scientists should be able to grow a human heart by taking stem cells from a patient's bone marrow and placing them in a cadaver heart that has been prepared as a scaffold, Ms. Taylor said in a telephone interview from her laboratory in Minneapolis. Todd N. McAllister of Cytograft Tissue Engineering in Novato, Calif., said, 'Doris Taylor's work is one of those maddeningly simple ideas that you knock yourself on the head, saying, 'Why didn't I think of that?'' Mr. McAllister's team has used a snippet of a patient's skin to grow blood vessels in a laboratory, and then implanted them to restore blood flow around a patient's damaged arteries and veins.

The highly experimental procedure, performed within the last two weeks, was the world's fourth partial face transplant, the country's first, and the most extensive and complicated such operation to date. 'This is not cosmetic surgery in any conventional sense,' said Dr. Eric Kodish, chair of the clinic's bioethics department, who was part of the team that interviewed and evaluated the patient's understanding of the risks in the experimental procedure. In late 2004, a Cleveland Clinic institutional review board said a face transplant was ethical and possible and approved [Maria Siemionow]'s scientific blueprint for the experimental procedure. It was the first time any ethics committee in the world had given such permission.

''We can say we have a culprit with the smoking gun at the scene of the crime, but that still doesn't mean he's guilty,'' Dr. [Patrick S. Moore] said in a telephone interview. ''We have a long way to go to prove that this agent is really the cause,'' he said. ''But the fact that the virus is so strongly associated with the tumor is at least a very good bet that it is playing an important role.'' ''It is not every day,'' Dr. [Anthony S. Fauci] said, ''that you have some pretty compelling molecular proof that a virus is associated, likely causally, with development of a particular cancerous process.''

Dr. Endo, 74, was chosen for ushering in a new era in preventing and treating coronary heart disease, the leading cause of death in the United States and many other countries, said Dr. Joseph L. Goldstein, chairman of the 24-member scientific jury that selects the Lasker recipients

The institute said the other half of the award would be shared equally by two French virologists, Dr. Francoise Barre-Sinoussi and Dr. Luc Montagnier, for discovering HIV, the virus that causes AIDS. Since its discovery in 1981, AIDS has rivaled the worst epidemics in history. An estimated 25 million people have died, and 33 million more are living with HIV. The Karolinska Institute said that discovery of HIV by the French scientists, Barre-Sinoussi and Montagnier, led to blood tests to detect the infection and to antiretroviral drugs that are effective in prolonging the lives of patients. The tests are now used to screen blood donations, making the blood supply safer for transfusions. The viral discovery has also led to an understanding of the natural history of HIV infection in people, which ultimately leads to AIDS unless treated. Dr. John Niederhuber, director of the National Cancer Institute, said Monday that Gallo 'was instrumental in every major aspect of the discovery of the AIDS virus.' He added: 'Dr. Gallo discovered interleukein-2, an immune-system-signaling molecule, which was necessary for the discovery of the AIDS virus, serving as a co-culture factor that allowed the virus to grow. Numerous scientific journal articles, many co-authored by Dr. Gallo and Dr. Luc Montagnier, cite the two scientists as co-discoverers of the AIDS virus.'

Another plenary speaker, Dr. Bruno Spire, the president of AIDES, a nongovernmental group in France, also called for improving laws and policies to combat stigma and discrimination against groups most vulnerable to H.I.V., typically gay and bisexual men, injecting drug users and sex workers

There was 'a 'planting and eating soybean' project for people living with H.I.V./AIDS in rural Anhui, China,' 'situational analysis and client satisfaction evaluation of A.R.T. centers in India' and 'coordinating procurement planning using logistics data,' to name but a few such studies